Iovance Biotherapeutics, Inc. (IOVA) quarterly income statement — complete revenue, gross profit & net income history
Iovance Biotherapeutics, Inc. (IOVA) annual income statement — 18-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 121.47M | 99.31M | 71.43M | 86.77M | 67.45M | 59.95M | 49.32M | 73.69M | 58.55M | 31.11M | 715K | 482K | 469K | 238K | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 80.07% | 65.65% | 44.82% | 17.75% | 15.2% | 92.73% | 6798.46% | 15189.21% | 12384.86% | 12969.75% | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 48.03M | 43.59M | 42.5M | 43.11M | 38.48M | 48.88M | 42.72M | 45.54M | 39.82M | 31.37M | 7.26M | 4.37M | 4.34M | 2.05M | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 39.54% | 43.9% | 59.5% | 49.68% | 57.04% | 81.53% | 86.6% | 61.8% | 68.01% | 100.84% | 1015.52% | 905.6% | 925.37% | 861.34% | - | - | - | - | - | - |
| Gross Profit | 73.44M | 55.72M | 28.93M | 43.66M | 28.98M | 11.07M | 6.61M | 28.15M | 18.73M | -262K | -6.55M | -3.88M | -3.87M | -1.81M | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 60.46% | 56.1% | 40.5% | 50.32% | 42.96% | 18.47% | 13.4% | 38.2% | 31.99% | -0.84% | -915.52% | -805.6% | -825.37% | -761.34% | - | - | - | - | - | - |
| Gross Profit Growth % | 153.44% | 403.28% | 337.77% | 55.09% | 54.71% | 4325.57% | 200.96% | 824.98% | 583.88% | 85.54% | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 97.41M | 107.62M | 109.97M | 117.12M | 118.74M | 124.84M | 127.83M | 114.73M | 107.8M | 101.65M | 111.18M | 117.37M | 114.49M | 108.27M | 110.86M | 107.04M | 100.39M | 99.73M | 91.71M | 99.47M |
| OpEx % of Revenue | 80.19% | 108.37% | 153.96% | 134.98% | 176.02% | 208.24% | 259.16% | 155.68% | 184.1% | 326.79% | 15549.09% | 24351.24% | 24411.51% | 45493.28% | - | - | - | - | - | - |
| Selling, General & Admin | 38.58M | 39.27M | 38.95M | 36.4M | 34.55M | 37.57M | 43.8M | 42.5M | 39.55M | 34.19M | 26.12M | 29.9M | 26.96M | 21.93M | 28.12M | 26.46M | 27.89M | 26.33M | 23.41M | 23.85M |
| SG&A % of Revenue | 31.76% | 39.54% | 54.53% | 41.95% | 51.23% | 62.66% | 88.8% | 57.67% | 67.55% | 109.91% | 3653.01% | 6203.94% | 5749.25% | 9213.03% | - | - | - | - | - | - |
| Research & Development | 49.34M | 58.85M | 62.49M | 71.2M | 75.17M | 77.93M | 75.97M | 72.22M | 68.25M | 62.08M | 79.78M | 87.47M | 87.53M | 86.35M | 82.73M | 80.57M | 72.5M | 73.41M | 68.3M | 75.62M |
| R&D % of Revenue | 40.62% | 59.26% | 87.48% | 82.06% | 111.44% | 129.98% | 154.01% | 98.01% | 116.55% | 199.59% | 11158.46% | 18147.3% | 18662.26% | 36280.25% | - | - | - | - | - | - |
| Other Operating Expenses | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | -1K | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -23.97M | -51.91M | -81.04M | -73.46M | -89.76M | -113.77M | -121.22M | -86.58M | -89.07M | -101.91M | -117.72M | -121.26M | -118.36M | -110.09M | -110.86M | -107.04M | -100.39M | -99.73M | -91.71M | -99.47M |
| Operating Margin % | -19.73% | -52.26% | -113.46% | -84.66% | -133.06% | -189.78% | -245.76% | -117.48% | -152.11% | -327.63% | -16464.62% | -25156.85% | -25236.89% | -46254.62% | - | - | - | - | - | - |
| Operating Income Growth % | 73.3% | 54.38% | 33.14% | 15.15% | -0.78% | -11.64% | -2.97% | 28.6% | 24.75% | 7.42% | -6.19% | -13.29% | -17.9% | -10.38% | -20.87% | -7.61% | -16.41% | -22.48% | -21.36% | -45.13% |
| EBITDA | -14.47M | -41.5M | -70.63M | -60.82M | -78.24M | -101.55M | -110.29M | -74.89M | -77.92M | -91.05M | -107.81M | -111.54M | -108.49M | -102.25M | -105.16M | -101.33M | -95.19M | -94.49M | -86.73M | -87.25M |
| EBITDA Margin % | -11.91% | -41.79% | -98.88% | -70.09% | -115.99% | -169.38% | -223.59% | -101.62% | -133.07% | -292.71% | -15079.02% | -23141.49% | -23131.34% | -42960.08% | - | - | - | - | - | - |
| EBITDA Growth % | 81.5% | 59.13% | 35.96% | 18.79% | -0.41% | -11.53% | -2.29% | 32.86% | 28.18% | 10.95% | -2.53% | -10.08% | -13.96% | -8.21% | -21.24% | -16.14% | -15.7% | -20.14% | -19.15% | -27.91% |
| D&A (Non-Cash Add-back) | 9.5M | 10.4M | 10.41M | 12.64M | 11.52M | 12.23M | 10.94M | 11.69M | 11.15M | 10.86M | 9.91M | 9.71M | 9.88M | 7.84M | 5.7M | 5.71M | 5.2M | 5.25M | 4.98M | 12.21M |
| EBIT | -21.66M | -51.91M | -81.04M | -73.46M | -89.76M | -113.77M | -121.22M | -77M | -89.07M | -98.56M | -114.38M | -121.26M | -118.36M | -110.09M | -110.86M | -107.04M | -100.39M | -99.73M | -91.71M | -99.47M |
| Net Interest Income | 2.31M | 3.22M | 1.33M | 1.74M | 1.24M | 4.1M | 3.22M | 9.57M | 4M | 3.35M | 3.34M | 3.12M | 3.36M | 3.08M | 3.49M | 1.72M | 777K | 385K | 106K | 135K |
| Interest Income | 2.31M | 3.22M | 1.33M | 1.74M | 1.24M | 4.1M | 3.22M | 9.57M | 4M | 3.35M | 3.34M | 3.12M | 3.36M | 3.08M | 3.49M | 1.72M | 777K | 385K | 106K | 135K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.31M | 3.22M | 1.33M | 1.74M | -3.9M | 4.1M | 3.22M | 9.57M | 4M | 3.35M | 3.34M | 3.12M | 3.36M | 3.08M | 3.49M | 1.72M | 777K | 385K | 106K | 135K |
| Pretax Income | -21.66M | -48.69M | -79.71M | -71.72M | -93.66M | -109.67M | -118M | -77M | -85.06M | -98.56M | -114.38M | -118.14M | -115M | -107M | -107.37M | -105.32M | -99.62M | -99.35M | -91.61M | -99.33M |
| Pretax Margin % | -17.83% | -49.02% | -111.59% | -82.65% | -138.85% | -182.93% | -239.24% | -104.49% | -145.27% | -316.85% | -15997.76% | -24509.96% | -24520.9% | -44960.08% | - | - | - | - | - | - |
| Income Tax | 614K | -1.37M | -665K | 184K | -2.4M | 1.99M | -1.84M | 1.56M | -1.52M | -1.46M | -1.41M | -1.76M | -1.24M | -477K | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -2.84% | 2.82% | 0.83% | -0.26% | 2.57% | -1.81% | 1.56% | -2.02% | 1.79% | 1.48% | 1.23% | 1.49% | 1.08% | 0.45% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -22.27M | -47.31M | -79.05M | -71.9M | -91.25M | -111.66M | -116.16M | -78.56M | -83.54M | -97.1M | -112.98M | -116.38M | -113.76M | -106.53M | -107.37M | -105.32M | -99.62M | -99.35M | -91.61M | -99.33M |
| Net Margin % | -18.33% | -47.64% | -110.66% | -82.87% | -135.28% | -186.25% | -235.51% | -106.6% | -142.67% | -312.16% | -15800.84% | -24145.02% | -24255.86% | -44759.66% | - | - | - | - | - | - |
| Net Income Growth % | 75.59% | 57.63% | 31.95% | 8.47% | -9.23% | -14.99% | -2.82% | 32.5% | 26.56% | 8.85% | -5.22% | -10.5% | -14.2% | -7.23% | -17.21% | -6.03% | -15.67% | -22.12% | -21.42% | -45.23% |
| Net Income (Continuing) | -22.27M | -47.31M | -79.05M | -71.9M | -91.25M | -111.66M | -116.16M | -78.56M | -83.54M | -97.1M | -112.98M | -116.38M | -113.76M | -106.53M | -107.37M | -105.32M | -99.62M | -99.35M | -91.61M | -99.33M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.05 | -0.11 | -0.19 | -0.18 | -0.25 | -0.33 | -0.36 | -0.26 | -0.28 | -0.34 | -0.42 | -0.45 | -0.46 | -0.47 | -0.50 | -0.62 | -0.63 | -0.63 | -0.58 | -0.63 |
| EPS Growth % | 80% | 66.67% | 47.22% | 30.77% | 10.71% | 2.94% | 14.29% | 42.22% | 39.13% | 27.66% | 16% | 27.42% | 26.98% | 25.4% | 13.79% | 1.59% | -14.55% | -18.87% | -13.73% | -34.04% |
| EPS (Basic) | -0.05 | -0.11 | -0.19 | -0.18 | -0.25 | -0.33 | -0.36 | -0.26 | -0.28 | -0.34 | -0.42 | -0.45 | -0.46 | -0.47 | -0.50 | -0.62 | -0.63 | -0.63 | -0.58 | -0.63 |
| Diluted Shares Outstanding | 455.92M | 450.19M | 418.51M | 406.97M | 364.04M | 334.51M | 322.87M | 304.89M | 303.27M | 284.82M | 266.22M | 255.95M | 245.82M | 224.48M | 213.69M | 164.76M | 157.82M | 157.27M | 157.11M | 156.92M |
| Basic Shares Outstanding | 455.92M | 450.19M | 418.51M | 406.97M | 364.04M | 334.51M | 322.87M | 304.89M | 303.27M | 284.82M | 266.22M | 255.95M | 245.82M | 224.48M | 213.69M | 164.76M | 157.82M | 157.27M | 157.11M | 156.92M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |